lobbying_activities: 756390

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
756390	d2a68dd2-37f7-434b-a489-87b55473e1ec	Q1	THE UNITED STATES PHARMACOPEIAL CONVENTION	400358632	THE UNITED STATES PHARMACOPEIAL CONVENTION	2009	first_quarter	FOO	-GAO Study on Dietary Supplement Regulation, provided comments for. -HR 759 "The Food and Drug Administration Globalization Act of 2009", regarding provisions on drugs and food ingredients with specific reference to drug quality, food quality and compendial modernization. -Letter to DHHS Secretary Designate regarding FDA Mission on drug quality, food quality, standards and follow-on biologics. -Letter to Acting Commissioner of the FDA regarding FDA budget and standards. -Communication with Congress on standards of use for heparin and glycerin. -Communication with FDA regarding drug quality, food quality and follow-on biologics and FDA resources. -Letter to President Obama regarding food safety. -Letter to Congress on legislative issues before Congress regarding drug quality, food quality and follow-on biologics and FDA resources. -Letter to FDA Commissioner-Designate regarding FDA resources, drug quality and food quality. -S 510 "FDA Food Safety Modernization Act", regarding all provisions with respect to food ingredient quality.	Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,President of the U.S.,SENATE		100000	0	0	2009-04-17T12:18:28-04:00